During the past decade, Hautzentrum am Starnberger See conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hautzentrum am Starnberger See" are "Facial Rhytides" (1 trials), "Glabellar Lines" (1 trials), "Glabellar Rhytides" (1 trials), "Moderate to Severe Glabellar Lines" (1 trials) and "Subcutaneous Fat" (1 trials). Many other conditions were trialed in "Hautzentrum am Starnberger See" in a lesser frequency.

Most popular intervention types in "Hautzentrum am Starnberger See" are "Drug" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Botulinum toxin type A" (2 trials), "Deoxycholic acid Injection" (1 trials), "Normal Saline" (1 trials) and "OnabotulinumtoxinA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hautzentrum am Starnberger See" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hautzentrum am Starnberger See". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hautzentrum am Starnberger See, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hautzentrum am Starnberger See, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".